325 related articles for article (PubMed ID: 8610726)
1. Parathyroid-hormone-related peptide in hematologic malignancies.
Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
3. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia.
Imamura H; Koreeda Y; Okadome T; Tara M; Niina K; Shizume K; Ohsumi K; Sato K
Jpn J Clin Oncol; 1992 Oct; 22(5):325-30. PubMed ID: 1469794
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
6. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
Body JJ; Dumon JC; Thirion M; Cleeren A
J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
8. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
[TBL] [Abstract][Full Text] [Related]
10. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia.
Takasaki H; Kanamori H; Takabayashi M; Yamaji S; Koharazawa H; Taguchi J; Fujimaki K; Ishigatsubo Y
Am J Hematol; 2006 Jun; 81(6):439-42. PubMed ID: 16680736
[TBL] [Abstract][Full Text] [Related]
12. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions.
Kao PC; Klee GG; Taylor RL; Heath H
Mayo Clin Proc; 1990 Nov; 65(11):1399-407. PubMed ID: 1700240
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia.
Bucht E; Rong H; Pernow Y; Nordqvist AC; Eriksson E; Rankin W; von Schoultz E; Burtis WJ; Granberg B; Falkmer UG; Burton DW; Deftos LJ
Cancer Res; 1998 Sep; 58(18):4113-6. PubMed ID: 9751621
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
[TBL] [Abstract][Full Text] [Related]
17. Interplay of parathyroid hormone-related peptide (PTHrP), renal insufficiency and bulky disease in the pathogenesis of hypercalcemia in Hodgkin's lymphoma (HL).
Chevalier N; Udi J; Sigler M; Wolf ME; Heinz J; Schmitt-Graeff A; Seufert J; Wäsch R; Engelhardt M
Eur J Haematol; 2010 Oct; 85(4):368-9. PubMed ID: 20561035
[No Abstract] [Full Text] [Related]
18. [PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia].
Scharla SH; Pecherstorfer M; Lempert UG; Minne HW; Sarrach M; Baumgartner G; Ziegler R
Med Klin (Munich); 1991 Apr; 86(4):186-9. PubMed ID: 2056982
[TBL] [Abstract][Full Text] [Related]
19. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
